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1. Introduction 
Development of novel chemotherapeutic agents is an 
important and challenging task for the medicinal chemists and many 
research programs are directed towards the design and synthesis of new 
drugs for their chemotherapeutic usage. There is an urgent need for 
identification of novel lead structure for the designing of new, potent, and 
less toxic agents which ideally shorten the duration of therapy and are 
effective against resistant strain [1]. Thiazolidinedione compounds 
constitute an important class for new drug development in order to 
discover an effective compound against multidrug resistant microbial 
infection. Thiazolidinediones have been demonstrated to possess 
antidiabetic [2-4], neuroprotective[5], antibacterial [6-7], antitumour [8], 
antihyperlipidemic[9], anti-inflammatory, antioxidant[10], antithyroid 
[11], antiviral[12], anticancer [13-15] activities. These reports prompted 
us to synthesize the novel derivatives of 2,4-Dioxothiazolidine which 
would be effective against various strains of microorganisms[16-17]. 
Thiazolidinedione derivatives are also employed to treat CHF [18] & 
some other heart related problems [19-20]. The structures of all 
compounds have been evaluated by spectral analysis (IR and 1H NMR). 
All the compounds have been screened for antimicrobial activity against 
two Gram positive bacteria S. aureus, B. subtilis and two Gram negative 
bacteria E. coli, P. aeruginosa and also against two fungal strains C. 
albicans and A. niger. Some of the synthesized compounds showed good 
antimicrobial activity against these strains even better than Ciprofloxacin 
and Clotrimazole (Table 2). 
 
2. Materials and Methods 
All reactions were monitored by thin layer chromatography 
(TLC) using silica gel G (Spectrochem Pvt. Ltd., Mumbai). The plates were 
developed by exposing to iodine chamber. Melting points (m.p.) were 
determined by decibel melting point apparatus and were uncorrected. 
Physicochemical data of all synthesized compounds is given in Table 1. 
Structures of the newly synthesized 2,4-thiazolidinedione derivatives 
have been ascertained on the basis of their consistent IR and 1H NMR 
spectral assignments. The IR spectra were recorded on Perkin Elmer IR 
spectro- photometer using KBr pellets. Proton nuclear magnetic 
resonance spectra (1H NMR) were recorded on Brucker Avance II 400 
NMR spectrophotometer using DMSO as solvent and TMS as internal 
standard and reported as chemical shift in δ values (ppm).  
 
2.1. Chemistry 
A general strategy for the synthesis of thiazolidine-2,4-diones 
is shown in Scheme 1. Perkin condensation of aryl aldehyde 1 with 4-
hydroxyphenyl acetic acid 2 in the presence of acetic anhydride and 
triethylamine yielded the 3-Aryl-2-(4-hydroxyphenyl)-acrylic acid 3. 
Esterification of this substituted acid followed by condensation with 4-
fluorobenzaldehyde in the presence of sodium hydride in dimethyl 
formamide yielded 3-Aryl-2-[4-(4-formylphenoxy)-phenyl]-acrylic acid 
alkyl ester 5. Knovenagel condensation of this ester with 2,4-
thiazolidinedione in the presence of piperidinium benzoate followed by 
hydrogenation gave a good yield of final compound 3-Aryl-2-{4-[4-(2,4-
dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl} -acrylic acid alkyl ester 7. 
A major challenge was selective hydrogenation of one of the double bond. 
Hydrogenation with 10% palladium on carbon as catalyst yielded 
mixture of products. By using ammonium formate as hydrogen donor in 
the presence of palladium catalyst produced minimal amounts of other 
products, and isolation of desired compounds in high purity was possible 
by repeated crystallization from methanol. 
Abstract 
Objective: To develop a series of 2,4-dioxothiazolidine derivatives of aryl substituted cinnamic 
acid, characterization by elemental and spectral (IR, 1H-NMR) studies and antimicrobial study.  
Method: All compounds were synthesized from pure & standard substrates. Reactions were 
monitored by TLC & Melting points were determined by decibel melting point apparatus. The IR 
spectra were recorded on Perkin Elmer IR spectrophotometer using KBr pellets. Proton nuclear 
magnetic resonance spectra (1H NMR) were recorded on Brucker Avance II 400 NMR 
spectrophotometer. Antimicrobial activity was performed by measuring zone of inhibition.  
Results: All the synthesized compounds were purified and give very good spectra of IR & NMR. 
Compunds were studied for their antimicrobial activity in comparison to the standard drugs. 
Thz 9 was found the most active compound in this series, where Ciprofloxacin was used as a 
standard drug for antibacterial activity and Clotrimazole for antifungal activity.  
Conclusion: Compound Thz9 exhibited highest antimicrobial activity due to substitution of aryl 
ring by electron releasing methoxy groups at -ortho and -para position. Compound Thz9 was 
found more active than all other dimethoxy substituted compounds, the reason behind it may 
be that dimethoxy substitutions at -ortho and -para position on aryl ring enhanced the binding 
of molecule with the target. Almost in all compounds propyl ester has higher activity than 
methyl, ethyl esters, which means that heavy carbon chain ester increase the antimicrobial 
activity.  
Chawla A and Chawla P/ Synthesis, Characterization and Biological Evaluation of Novel 2,4-Dioxothiazolidine Derivatives 
 
© ASD Publisher All rights reserved.                                                                                                                                                                                                                       59 
Ar-CHO
COOH
OH
Ar
+
COOR
OH
Ar
COOH
OH
COOR
O
Ar
CHO
COOR
O
Ar
S
NH
O
O
COOR
O
Ar
S
NH
O
O
ba c
d e
   1                     2                               3                                 4
            5                                                 6                                                 7  
Scheme 1: Synthetic scheme for the synthesis of 3-Aryl-2-{4-[4-(2,4-
dioxothiazolidin-5-ylmethyl)phenoxy]-phenyl}-acrylic acid alkyl 
ester (Reagents and conditions: (a) acetic anhydride, Et3N, 6 hrs, 130°C; 
(b) ROH, H2SO4, 15 hrs, reflux; (c) 4-fluorobenzaldehyde, NaH, DMF, 18 
hrs, 80°C; (d) 2,4-thiazolidinedione, piperidine, benzoic acid, toluene, 5 
hrs, reflux; (e) Pd/C (10%), AcOH–HCOONH4, 15 hrs, 125°C) 
 
2.2. General procedure for the synthesis of 3-Aryl-2-{4-[4-(2,4-
dioxothiazolidin-5-ylmethyl) phenoxy]-phenyl}-acrylic acid alkyl 
ester (Thz1-15): 
2.2.1. 3-Aryl-2-(4-hydroxyphenyl)–acrylic acid (3): 
To a mixture of aryl aldehyde, (10 g, 0.06 mol) and 4-
hydroxyphenylacetic acid (9.14 g, 0.06 mol) in a conical flask, acetic anhydride 
(20 mL, 0.212 mol) and triethylamine (8.4 mL, 0.06 mol) were added. The 
resulting mixture was heated at 130°C –140°C for 6 hrs with continuous 
stirring. Then it was cooled to room temperature. Concentrated HCl (20 mL) 
was added to the reaction mixture slowly over 30 min, while keeping the 
temperature of the mixture between 20-30°C. The resulting precipitate was, 
filtered and washed with water to give crude product (3) that was 
recrystallized from methanol-water (4:1) and dried at 40°C. 
2.2.2. 3-Aryl-2-(4-hydroxyphenyl)–acrylic acid alkyl ester (4): 
Alkylalcohol (60 mL) was added to the completely dried 
compound 3 (8.55 g, 0.028 mol) in RBF. Conc. sulfuric acid (2 mL) was 
added to the above suspension and the reaction mixture was refluxed for 
15 hrs under nitrogen. Then filtered the resulting mixture and residue 
was taken in ethyl acetate (60 mL) in separating funnel and washed 
sequentially with water (2×20 mL), saturated aqueous NaHCO3 (2×20 
mL) and brine (2×20 mL). The organic layer was passed through 
anhydrous magnesium sulfate to remove any traces of water and filtered. 
Then the solvent was evaporated to dryness at water bath and compound 
4 was obtained. 
2.2.3. 3-Aryl-2-[4-(4-formylphenoxy)-phenyl]-acrylic acid alkyl ester (5): 
Compound 4 (8.66 g, 0.027 mol) was taken in a conical flask and 
dissolved in dry DMF (32 mL) and sodium hydride (1.2 g, 0.03 mol) was 
added. To the resulting orange solution, 4-fluorobenzaldehyde (3.7 mL, 0.034 
mol) was added. The resulting solution was heated at 80°C for 18 hrs with 
continuous stirring. The reaction mixture was cooled to room temperature, 
diluted with ethyl acetate (60 mL) and washed first with water (3×20 mL) 
and then brine (1×20 mL). The organic layer was passed through anhydrous 
sodium sulfate, filtered and solvent was evaporated. The residue was 
suspended in methanol (60 mL) and then filtered to get compound 5 which 
were dried at 40°C. 
2.2.4. 3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylidenmethyl)-phenoxy]-
phenyl}-acrylic acid alkyl ester (6): 
To a suspension of 5 (7.04 g, 0.016 mol) in anhydrous toluene 
(50 mL), 2,4-thiazolidinedione (1.97 g, 0.017 mol), benzoic acid (2.68 g, 
0.022 mol) and piperidine (2.14 g, 0.025 mol) were added sequentially  
with continuous stirring. The resulting mixture was taken in a RBF and 
refluxed for 5 hrs. After refluxing the reaction mixture was cooled to 
room temperature and the resulting compound was filtered and washed 
with water. The residue so obtained was recrystallized in a mixture of 
methanol-diethyl ether (1 : 1, 60 mL). The compound 6 was obtained and 
dried in oven at 40°C. 
2.2.5. 3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy]-
phenyl}- acrylic acid alkyl ester (7): 
To a solution of 6 (7.04 g, 0.013 mol) in glacial acetic acid (120 mL) 
in a conical flask, ammonium formate (47.06 gm, 0.74 mol) was added and 
stirred for 30 min. Slurry of Pd on carbon (10%, dry, 3.52 g) in glacial acetic 
acid (5.8 mL) was added to the flask and heated at 125°C for 15 hrs with 
continuous stirring. The resulting mixture was filtered and the filtrate was 
poured slowly into water (140 mL) with vigourous stirring and the solid 
that separated, was filtered and dried. The resulting solid was recrystallized 
in a mixture of methanol and ethanol (2:1) to yield compound 7. 
 
2.3. Spectral data of some compounds from each category:  
3-Phenyl-2-{4-[4-(2,4-thiazolidin-5-methyl) phenoxy]-phenyl}-acrylic 
acid methyl ester (Thz1): 
COOCH3
O
S
NH
O
O
 
1H-NMR, δ ppm (400 MHz, DMSO): 1.06-1.13 (s, 3H, COOCH3), 7.06-7.31 (m, 
8H, ArH-O-ArH), 7.35-7.58 (m, 5H, ArH), 7.04-7.12 (s, 1H, CH of Ar-CH=C<), 
8.26 (s, 1H, NH), 3.64-3.72 (d, 2H, CH2 of Ar-CH2-Thz). 
IR, cm-1 (KBr Pelletes): 1706.6 (C=O str., ketonic), 1734.1 (C=O str., COOCH3), 
3029.1 (C-H str., aromatic), 2835.3 (C-H str., aliphatic), 3214.0 (NH str.), 
1268.4 (Ar-O-SAr str.), 1494.2 (C=C str., aromatic). 
 
3-(4-Methoxyphenyl)-2-{4-[4-(2,4-thiazolidin-5-ylmethyl) phenoxy]-
phenyl} - acrylic acid methyl ester (Thz4): 
COOCH3
O
S
NH
O
O
H3CO
 
1H-NMR, δ ppm (400 MHz, DMSO): 1.34-1.57 (s, 3H, COOCH3), 3.75-4.0 (s, 3H, 
OCH3), 7.2-7.9 (m, 12H, Ar-H), 7.00 (s, 1H, CH of Ar-CH=C <), 8.5 (s, 1H, NH), 
3.59 (d, 2H, CH2 of Ar-CH2-Thz). 
IR, cm-1 (KBr Pelletes): 1694.7 (C=O str., ketonic), 1734.1 (C=O str., COOCH3), 
3030.1 (C-H str., aromatic), 2835.3 (C-H str., aliphatic), 3214.0 (NH str.), 
1286.7 (Ar-O-Ar str.), 1507.6 (C=C str., aromatic). 
 
3-(2,4-Dimethoxyphenyl)-2-{4-[4-(2,4-thiazolidin-5-ylmethyl) phenoxy] 
- phenyl}-  acrylic acid   ethyl ester (Thz8): 
COOC2H5
O
S
NH
O
O
H3CO
OCH3
 
1H-NMR, δ ppm (400 MHz, DMSO): 1.14-1.18 (d, 5H, COOC2H5), 3.75-3.95 (s, 
6H, OCH3), 7.14-7.51 (m, 8H, ArH-O-ArH), 6.7-6.76 (m, 3H, ArH) 6.9-6.96 (s, 
1H, CH of Ar-CH=C <), 8.21 (s, 1H, NH), 3.58 (d, 2H, CH2 of Ar-CH2-Thz). 
IR, cm-1 (KBr Pelletes): 1673.0 (C=O str., ketonic), 1731.8 (C=O str., COOC2H5 ), 
2941.0 (C-H str., aromatic), 2832.3 (C-H str., aliphatic), 3143.1 (NH str.), 
1284.4 (Ar-O-Ar str.), 1461.8 (C=C str., aromatic). 
3-(3,4-Dimethoxyphenyl)-2-{4-[4-(2,4-thiazolidin-5ylmethyl) 
phenoxy] -phenyl}-acrylic acid ethyl ester (Thz11): 
COOC2H5
O
S
NH
O
O
H3CO
H3CO
 
1H-NMR, δ ppm (400 MHz, DMSO): 1.14-1.18 (d, 5H, COOC2H5), 3.92-3.94 (s, 
6H, OCH3), 7.22-7.38 (m, 11H, ArH), 7.14 (s, 1H, CH of Ar-CH=C <), 8.22 (s,1H, 
NH), 3.72 (d, 2H, CH2 of Ar-CH2-Thz). 
IR, cm-1 (KBr Pelletes): 1706.6 (C=O str., ketonic), 1734.1 (C=O str., COOC2H5 ), 
3053.8 (C-H str., aromatic), 2835.3 (C-H str., aliphatic), 3214.0 (NH str.), 
1265.3 (Ar-O-Ar str.), 1449.6 (C=C str., aromatic). 
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3-(2,3-Dimethoxyphenyl)-2-{4-[4-(2,4-thiazolidin-5ylmethyl)phenoxy]-
phenyl}-acrylic acid methyl ester (Thz13): 
COOCH3
O
S
NH
O
O
OCH3
H3CO
 
1H-NMR, δ ppm (400 MHz, DMSO): 1.14-1.18 (s, 3H, COOCH3), 3.72-3.98 (s, 
6H, OCH3), 7.13-7.34 (m, 11H, ArH), 7.0-7.06 (s, 1H, CH of Ar-CH=C <), 8.22 (s, 
1H, NH), 3.64 (d, 2H, CH2 of Ar-CH2-Thz). 
IR, cm-1 (KBr Pelletes): 1701.6 (C=O str., ketonic), 1737.7 (C=O str., COOCH3), 
3028.8 (C-H str., aromatic), 2835.8 (C-H str., aliphatic), 3143.1 (NH str.), 
1273.0 (Ar-O-Ar str.), 1454.0 (C=C str., aromatic). 
 
Table 1: Physicochemical characteristics of synthesized 3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy]-phenyl}-acrylic acid 
alkyl esters 
Ar
COOR
O
S
NH
O
O
 
Comp. -Ar -R Mol. Formula Mol. Wt. M.P. (°C) Rf % yield 
Thz1 
 
-CH3 C26H21NO5S 459.51 134-136 0.55 48.51 
Thz2 
 
-C2H5 C27H23NO5S 473.54 141-143 0.62 34.10 
Thz3 
 
-C3H7 C28H25NO5S 487.57 149-151 0.51* 52.09 
Thz4 MeO
 
-CH3 C27H23NO6S 489.54 117-119 0.57 38.34 
Thz5 MeO
 
-C2H5 C28H25NO6S 503.57 127-129 0.49 42.80 
Thz6 MeO
 
-C3H7 C29H27NO6S 517.59 121-123 0.58 29.21 
Thz7 
MeO
OMe
 
-CH3 C28H25NO7S 519.57 112-114 0.64 47.40 
Thz8 
MeO
OMe
 
-C2H5 C29H27NO7S 533.59 128-130 0.71 41.70 
Thz9 
MeO
OMe
 
-C3H7 C30H29NO7S 547.62 123-125 0.59 33.28 
Thz10 
MeO
MeO  
-CH3 C28H25NO7S 519.57 92-94 0.65 54.08 
Thz11 
MeO
MeO  
-C2H5 C29H27NO7S 533.59 97-99 0.56 46.90 
Thz12 
MeO
MeO  
-C3H7 C30H29NO7S 547.62 103-105 0.47* 53.45 
Thz13 
OMeMeO
 
-CH3 C28H25NO7S 519.57 99-101 0.54 32.58 
Thz14 
OMeMeO
 
-C2H5 C29H27NO7S 533.59 111-113 0.42 27.17 
Thz15 
OMeMeO
 
-C3H7 C30H29NO7S 547.62 106-108 0.45 41.52 
TLC mobile phase - Toluene: Chloroform (1:2), * Ethyl acetate: Benzene (1:2 ) 
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2.4. Antimicrobial Activity 
Nutrient agar media was used for bacterial growth [beef 
extract, 3g; bacteriological peptones, 5g; agar, 20g, the pH was adjusted 
to 6.2 + 0.2 at 25 (+2) °C], while malt extract agar (MEA) for fungal 
isolates [malt extract, 20 g; bacteriological peptone, 5g; agar, 20g, the pH 
was adjusted to 5.4 + 0.2 at 25 (+2) °C]. Each medium was prepared by 
dissolving the solid ingredient in 1 L of cold distilled water and then 
heated to 60-70 °C with stirring. Media were sterilized by autoclaving at 
121 °C (1.5 atm) for 15-20 min.  
By diffusion agar technique, the antibacterial and antifungal 
effects against several species are expressed as the measurement of 
diameter of their zone of inhibition. Four equidistant (1 cm diameter) 
holes were made using sterile cork borer in malt extract agar and 
nutrient agar sterile plates. Holes are filled with 100 µg/ml concentration 
of each of the synthesized compounds after completely dissolving in 
DMSO. Controlled holes were filled with DMSO solvent. Plates were left in 
a cooled incubator at 37 (+2) °C for bacterial isolates and incubation at 28 
(+2) °C for fungal isolates used. Zone of inhibition developed due to active 
ingredients were measured after 24-48 h of incubation time. 
Ciprofloxacin is used as standard antibacterial agent while Clotrimazole 
was used as a standard antifungal agent.    
 
 
 
 
3. Results 
The antimicrobial sensitivity testing of the synthesized 
compounds were assayed using cup plate technique in the nutrient agar 
at 100 µg/ml concentration is shown in table 2. Ciprofloxacin standard 
were active at 50 µg/ml on all the Gram (+ve) bacteria with a zone of 
inhibition for Bacillus subtilis MTCC 96 (24 mm), Staphylococcus aureus 
MTCC 121 (29 mm) and Gram (-ve) bacteria Pseudomonas aeruginosa 
MTCC 2453 (21 mm) and Escherichia coli MTCC 40 (28 mm). From the 
antibacterial screening, it was concluded that compounds Thz9, Thz12, 
Thz15 showed larger zone of inhibition as compare to standard drug 
Ciprofloxacin against Bacillus subtilis (28, 26, 27 mm), Staphylococcus 
aureus (34, 32, 32 mm) and Gram (-ve) bacteria Pseudomonas aeruginosa 
(25, 22, 23 mm) and Escherichia coli (33, 32, 31 mm). While compound 
Thz4, Thz5, Thz6 showed nearly moderate zone of inhibition as compare 
to Ciprofloxacin Bacillus subtilis (22, 24, 24 mm), Staphylococcus aureus 
(22, 23, 25 mm) and Gram (-ve) bacteria Pseudomonas aeruginosa (19, 
20, 19 mm) and Escherichia coli (25, 27, 27 mm). Clotrimazole standard 
were active at 50 µg/ml on most of the fungal strain with a zone of 
inhibition for Candida albicans MTCC 8184 (19 mm) and A. niger MTCC 
8189 (18 mm). From the antifungal screening, it was concluded that 
compounds Thz9, Thz12, Thz15 shows larger zone of inhibition as 
compare to standard drug Clotrimazole against Candida albicans (24, 21, 
24 mm) and A. niger (24, 21, 23 mm). While compound Thz4, Thz5, Thz6 
showed nearly moderate zone of inhibition as compare to Clotrimazole 
Candida albicans (15, 15, 16 mm), A. niger (15, 16, 17 mm). 
 
Table 2: Antimicrobial results of the synthesized and tested compounds 
Compound 
 
Concentration 
(µg/ml) 
Zone of inhibition (in mm) 
Gram positive Gram negative Fungal strain 
B. subtilis 
(MTCC 96) 
S. aureus 
(MTCC 121) 
P. aeruginosa 
(MTCC 2453) 
E.coli  
(MTCC 40) 
C. albicans  
(MTCC 8184) 
A. niger 
(MTCC 8189) 
Thz1 100 17 21 15 22 12 11 
Thz2 100 19 23 18 22 12 10 
Thz3 100 21 24 18 24 14 14 
Thz4 100 22 22 19 25 15 15 
Thz5 100 24 23 20 27 15 16 
Thz6 100 24 25 19 27 16 17 
Thz7 100 23 26 20 28 20 18 
Thz8 100 25 28 23 30 20 21 
Thz9 100 28 34 25 33 24 24 
Thz10 100 24 28 18 30 18 17 
Thz11 100 25 29 20 30 19 19 
Thz12 100 26 32 22 32 21 21 
Thz13 100 22 24 19 29 21 16 
Thz14 100 23 26 21 31 23 19 
Thz15 100 27 32 23 31 24 23 
Ciprofloxacin 50 24 29 21 28 - - 
Clotrimazole 50 - - - - 19 18 
 
4. Discussion 
The synthesized compounds were successfully screened for 
their antimicrobial activity. The highest antibacterial activity against 
Gram positive species Bacillus subtilis, Staphylococcus aeuras and Gram 
negative species Pseudomonas aeruginosa, Escherichia coli was shown by 
compounds Thz9, Thz12, Thz15. The compounds Thz9, Thz12, Thz15 
also exhibit highest antifungal activity against Candida albicans and A. 
niger species.  
Compounds Thz1-3 has no substitution on aryl ring and has 
minimal antimicrobial activity among all synthesized compounds. 
Compounds Thz4-6 having mono methoxy substitution on aryl ring, were 
found more active than unsubstituted compounds, but were found less 
active than compounds having dimethoxy substitution Thz9, Thz12, 
Thz15 on aryl ring. 
Compound Thz9 exhibited highest antimicrobial activity 
within all synthesized compounds, it may be due to substitution of aryl 
ring by electron releasing methoxy groups at -ortho and -para position. 
Chemically compound Thz9 is 3-(2,4-Dimethoxyphenyl)-2-{4-[4-(2,4-
thiazolidin -5-ylmethyl) phenoxy]-phenyl}-acrylic acid propyl ester. 
Compound Thz9 was found more active than all other dimethoxy 
substituted compounds, the reason behind it may be that dimethoxy 
substitutions at -ortho and -para position on aryl ring enhanced the 
binding of molecule with the target. Almost in all compounds propyl ester 
has higher activity than methyl, ethyl esters, which means that heavy 
carbon chain ester increase the antimicrobial activity. This may be due to 
higher lipophilicity developed by heavy ester groups increase the 
binding/interaction of compounds with target site. 
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